Where are we at?
We are at the hands of the FDA/TGA, now. Thanks Paul. Everyone is frustrated. Balance sheet is shot.
Paul (and Donna) either has supreme confidence in our data, is acting on the information at non binding agreement stages or is a complete fool. COMPLETE.
But if the regulators allow us to apply for the programs on offer (BT, AA, Provisional Approval) and our optimal dose is green lighted, we will re-rate if…… our cash position can change.
Matt and SW will (in my completely nativity) have 1 or 2 shots at obtaining a non dilutive funding and they should be able to achieve this.
Paul may redeem himself, hard to know
Where we at?, page-5
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.5¢ |
Change
0.005(2.17%) |
Mkt cap ! $82.20M | |||
| Open | High | Low | Value | Volume |
| 23.5¢ | 24.0¢ | 23.3¢ | $111.8K | 474.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 154744 | 23.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 21128 | 2 |
View Market Depth
| Last trade - 16.10pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
23.5¢ |
Change
0.005 ( 2.17 %) |
||||
| Open | High | Low | Volume | ||
| 23.5¢ | 24.0¢ | 23.5¢ | 63872 | ||
| Last updated 15.59pm 14/06/2024 ? | |||||
| PAR (ASX) Chart |